Casandra
Casandra Test Code QD74946Version 1 (DRAFT)
Performing Lab
BRAF Mutation Analysis
Also known as: BRAF Mutation Analysis, Oncomine Dx Target Test
Clinical Use
Order TestUse
Detects mutations in the BRAF gene, including clinically significant variants such as V600E (p.Val600Glu), which inform treatment options in metastatic cancers and melanomas.
Special Instructions
Not provided.
Limitations
This test is designed to detect gene mutations only. It is not intended to detect copy number changes or gene rearrangements.
Test Details
Methodology
Sanger
Biomarkers
BRAF
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
7-10 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Tumor Tissue (FFPE)
Volume
Not provided
Minimum Volume
Not provided
Container
Formalin-fixed, paraffin-embedded tissue block
Collection Instructions
For submission of paraffin block, tissue source and block ID are required on the requisition form. A pathology report must be submitted.
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | Unacceptable |
Related Tests
Other tests from different labs that may be relevant
BRAF Gene Mutation Analysis
Labcorp
BRAF Gene Mutation Analysis - Melanoma
Labcorp
BRAF V600E/V600K Somatic Mutation Analysis, Tumor
Mayo Clinic Lab
BRAF Mutation Analysis by PCR
NeoGenomics
Cell-Free DNA BRAF V600, Blood
Mayo Clinic Lab
BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
ARUP Laboratories
BRAF and KIT Mutation Analysis, Next-Generation Sequencing, Tumor
Mayo Clinic Lab
BRAF Codon 600 Mutation Detection by Pyrosequencing (Change effective as of 05/20/24: Refer to 3017203)
ARUP Laboratories
BRAF V600E
NeoGenomics
BRAF V600 Mutation Analysis
MPLN